Interferon action and chromosome 21 trisomy (Down Syndrome): 15 years later

被引:16
|
作者
Maroun, LE
机构
[1] Southern Illinois University, School of Medicine, Dept. of Med. Microbiology/ I., Springfield
关键词
D O I
10.1006/jtbi.1996.0113
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A hypothesis relating interferon action and the chromosome 21 trisomy genotype and phenotype was presented in this journal in 1980. Since that time a number of additional genes involved in interferon action have been mapped to the distal Down Syndrome region of chromosome 21 and a growing literature has documented highly relevant pleiotropic effects of interferon in the brain. Thus, interferon continues to provide a potential basis for the phenotypic anomalies seen in the interferon supersensitive Down Syndrome patient. Further, the hypothesis that ribosomal RNA gene ''satellite association'' induced by interferon action is involved in the induction of chromosome 21 misdistribution at meiosis, is supported by extension of the cyclic correlation of Down Syndrome prevalence and virus epidemics, first observed by Stoller & Collmann in Australia from 1942 to 1964, to incidence data gathered by the CDC in the U.S. from 1968 to 1992. In addition, data from spontaneous abortuses and gametes assembled from the literature argue for a uniquely high frequency of chromosome 21 hyperploidy which suggests that the genes present on chromosome 21 play a role in its frequent misdistribution at meiosis. Taken together, these observations provide continued support for the hypothesis presented in 1980 that interferon action could be involved in the induction of both the trisomy 21 genotype and its resultant phenotype. (C) 1996 Academic Press Limited
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [21] Introduction to session "Trisomy 21 Down Syndrome, fifty years on: where are we now?"
    Hulten, Maj
    JOURNAL OF MEDICAL GENETICS, 2009, 46 : S21 - S21
  • [22] TRISOMY-21 DOWN-SYNDROME .2. STRUCTURAL CHROMOSOME REARRANGEMENTS IN THE PARENTS
    UCHIDA, IA
    FREEMAN, VCP
    HUMAN GENETICS, 1986, 72 (02) : 118 - 122
  • [23] Lipid peroxidation in Down syndrome caused by regular trisomy 21, trisomy 21 by Robertsonian translocation and mosaic trisomy 21
    Casado, Angela
    Lopez-Fernandez, Ma Encarnacion
    Ruiz, Rocio
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (01) : 59 - 62
  • [24] The "genomics" of chromosome 21 and Down syndrome
    Scott, HS
    Antonarakis, SE
    GENETICS OF CARDIOPATHIES: NEW INFORMATIONS FROM MOLECULAR BIOLOGY METHODS, 1999, : 164 - 179
  • [25] Growth hormone neuropathology in Down syndrome (trisomy 21)
    Wisniewski, KE
    Castells, S
    Mandys, V
    DEVELOPMENTAL BRAIN DYSFUNCTION, 1996, 9 (2-3): : 100 - 113
  • [26] RECURRENCE OF TRISOMY-21 DOWN-SYNDROME
    BAEZ, MR
    MAYEN, DG
    GARCIACAVAZOS, RJ
    MELONDEZ, R
    ROCHA, F
    HERNANDEZ, C
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1790 - 1790
  • [27] Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down’s Syndrome and Trisomy-21 Linked Disease
    P. N. Alexandrov
    M. E. Percy
    Walter J. Lukiw
    Cellular and Molecular Neurobiology, 2018, 38 : 769 - 774
  • [28] Hypercalcaemia in association with trisomy 21 (Down's syndrome)
    Ramage, IJ
    Durkan, A
    Walker, K
    Beattie, TJ
    JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (07) : 543 - 544
  • [29] Consequences of trisomy 21 for brain development in Down syndrome
    Russo, Matthew L.
    Sousa, Andre M. M.
    Bhattacharyya, Anita
    NATURE REVIEWS NEUROSCIENCE, 2024, 25 (11) : 740 - 755
  • [30] TRISOMY-21 DOWN SYNDROME - PARENTAL MOSAICISM
    UCHIDA, IA
    FREEMAN, VCP
    HUMAN GENETICS, 1985, 70 (03) : 246 - 248